共 50 条
Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity
被引:72
作者:
Rasolofonjatovo, Evelia
[1
]
Provot, Olivier
[1
]
Hamze, Abdallah
[1
]
Rodrigo, Jordi
[1
]
Bignon, Jerome
[2
]
Wdzieczak-Bakala, Joanna
[2
]
Desravines, Deborah
[2
]
Dubois, Joelle
[2
]
Brion, Jean-Daniel
[1
]
Alami, Mouad
[1
]
机构:
[1] Univ Paris Sud, BioCIS UMR 8076, Fac Pharm, Chim Therapeut Lab,LabEx LERMIT,CNRS, F-92296 Chatenay Malabry, France
[2] Inst Chim Subst Nat, UPR 2301, F-91198 Gif Sur Yvette, France
关键词:
Combretastatin A-4;
isoCA-4;
Cytotoxicity;
Antimitotic;
Tubulin;
Restricted analogues;
COMBRETASTATIN A-4;
ANTINEOPLASTIC AGENTS;
ARYL HALIDES;
BIOLOGICAL EVALUATION;
ANTITUMOR-ACTIVITY;
N-TOSYLHYDRAZONES;
TUBULIN;
ACCESS;
DIARYLALKYNES;
MECHANISMS;
D O I:
10.1016/j.ejmech.2012.03.001
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
A novel series of dihydronaphtalene, tetrahydronaphtalene and naphtalene derivatives as restricted analogues of isoCA-4 were designed, synthesized and evaluated for their anticancer properties. High cell growth inhibition against four tumour cell lines was observed at a nanomolar level with dihydronaphtalenes 1d, e and 1h, tetrahydronaphtalene 2c and naphtalene 3c. Structure activity relationships are also considered. These compounds exhibited a significant inhibitory activity toward tubulin polymerization (IC50 = 2-3 mu M), comparable to that of isoCA-4. The effect of the lead compounds le and 2c on the cancer cells tested was associated with cell cycle arrest in the G(2)/M phase. Docking studies reveal that these compounds showed a binding mode similar to those observed with their non-constraint isoCA-4 and isoerianin congeners. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:22 / 32
页数:11
相关论文